ArticleClinical and molecular hepatology2024

Correspondence to editorial on "Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study".

Young Eun Chon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.